Harraden Circle Investments’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-50,000
Closed -$7K 221
2025
Q4
$7K Buy
+50,000
New +$7.14K ﹤0.01% 179

Other funds holding DMIIR

Harraden Circle Investments's DMIIR Position: Q1 2026 in Review

Harraden Circle Investments sold out of Drugs Made In America Acquisition II Corp Right (DMIIR) in Q1 2026, closing a stake of 50,000 shares — an estimated $7K sold.

Harraden Circle Investments first reported a position in DMIIR in Q4 2025 and held it in 1 quarter. The position peaked at $7K in Q4 2025. 57 funds tracked by Wall St. Rank hold DMIIR as of Q1 2026.

  • Harraden Circle Investments reported no remaining Drugs Made In America Acquisition II Corp Right position as of Q1 2026 after selling out during the quarter.
  • Harraden Circle Investments sold 50,000 Drugs Made In America Acquisition II Corp Right shares in Q1 2026, an estimated $7K.
  • Harraden Circle Investments first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and held it in 1 quarter.
  • Harraden Circle Investments's Drugs Made In America Acquisition II Corp Right position peaked at $7K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q1 2026.

Based on Harraden Circle Investments's 13F filing for Q1 2026, filed 15 May 2026.